Skip to main content

Advertisement

SpringerLink
Log in

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from the precursor of the plasmacytoid dendritic cell. It is very rare and has only recently been recognized as a distinct entity. In this study, we report our experience of BPDCN to review the clinical, pathological features and treatment outcomes. A database at the Asan Medical Center was screened for all patients with BPDCN treated between 2000 and 2010. Seven patients were confirmed as BPDCN and included in this analysis. The median age of the patients was 40 years (range, 18–62 years), and four patients were male. Sites of disease involvement included the skin (n = 4), lymph node (n = 4), and peripheral blood/bone marrow (n = 2). Tumor cells were positive for CD4 (n = 5), CD56 (n = 6), and CD123 (n = 7). Six patients received multi-agent chemotherapy as first-line treatment, while one patient was given radiotherapy. The median progression-free survival was 8.6 months (range, 2.6–28.9 months) and overall survival was 15.1 months (range, 4.4–60.0 months) with a median follow-up period of 13.8 months (range, 1.9–29.9 months). Notably, all four patients with cutaneous involvement survived, whereas those without skin involvement succumbed to death, even though two of them were given salvage chemotherapy. In this study, patients with BPDCN showed various clinical, histological, and immunophenotypical features. Our experience warrants further examination of the prognostic significance of skin involvement in BPDCN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Herling M, Jones D (2007) CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells. Am J Clin Pathol 127(5):687–700. doi:10.1309/fy6pk436nbk0ryd4

    Article  PubMed  Google Scholar 

  2. Facchetti FJD, Petrella T (2008) Blastic plasmacytoid dendritic cell neoplasm. WHO classification of tumors of haematopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  3. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Briere F, Plumas J, Jacob MC (2001) Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 97(10):3210–3217

    Article  PubMed  CAS  Google Scholar 

  4. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D’Incan M, Wechsler J, Teitell MA (2005) Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms): a review. Am J Clin Pathol 123(5):662–675

    Article  PubMed  Google Scholar 

  5. Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, Metze D, Fink-Puches R, Wiesner T, Cerroni L (2010) Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol 34(1):75–87. doi:10.1097/PAS.0b013e3181c5e26b

    Article  PubMed  Google Scholar 

  6. Argyrakos T, Rontogianni D, Karmiris T, Kapsimali V, Grigoriou E, Tsantekidou M, Naum C, Galani V, Pantelidaki C, Harhalakis N, Nikiforakis E, Kanavaros P (2004) Blastic natural killer (NK)-cell lymphoma: report of an unusual CD4 negative case and review of the CD4 negative neoplasms with blastic features in the literature. Leukemia & Lymphoma 45(10):2127–2133. doi:10.1080/10428190410001723232

    Article  Google Scholar 

  7. Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E, Tiberghien P, Bensa JC, Plumas J, Saas P (2005) Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 105(3):1256–1264. doi:10.1182/blood-2004-06-2416

    Article  PubMed  CAS  Google Scholar 

  8. Petrella T, Teitell MA, Spiekermann C, Meijer CJ, Franck F, Enache I (2004) A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol 150(1):174–176

    Article  PubMed  CAS  Google Scholar 

  9. Reimer P, Rudiger T, Kraemer D, Kunzmann V, Weissinger F, Zettl A, Konrad Muller-Hermelink H, Wilhelm M (2003) What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplantation 32(7):637–646. doi:10.1038/sj.bmt.1704215

    Article  PubMed  CAS  Google Scholar 

  10. Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drenou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Bene MC (2002) Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 99(5):1556–1563

    Article  PubMed  CAS  Google Scholar 

  11. Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010) Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematol 95(11):1873–1879. doi:10.3324/haematol.2010.026179

    Article  CAS  Google Scholar 

  12. Inoue D, Maruyama K, Aoki K, Nagano S, Maruoka H, Imai Y, Ito K, Ishikawa T, Takahashi T (2011) Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen. Acta Haematologica 126(2):122–128. doi:10.1159/000328180

    Article  PubMed  CAS  Google Scholar 

  13. Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G (2010) Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the hellenic dendritic cell leukemia study group. Leuk Res 34(4):438–446. doi:10.1016/j.leukres.2009.09.006

    Article  PubMed  CAS  Google Scholar 

  14. Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadie M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P, Jacob MC (2009) Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 145(5):624–636. doi:10.1111/j.1365-2141.2009.07679.x

    Article  PubMed  CAS  Google Scholar 

  15. Petrella T, Facchetti F (2010) Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009? Autoimmun 43(3):210–214. doi:10.3109/08916930903510898

    Article  CAS  Google Scholar 

  16. Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dompmartin A, D’Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald M, Fraitag S, Petrella T (2010) Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 162(1):74–79. doi:10.1111/j.1365-2133.2009.09373.x

    Article  PubMed  CAS  Google Scholar 

  17. Suzuki R, Nakamura S, Suzumiya J, Ichimura K, Ichikawa M, Ogata K, Kura Y, Aikawa K, Teshima H, Sako M, Kojima H, Nishio M, Yoshino T, Sugimori H, Kawa K, Oshimi K (2005) Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Cancer 104(5):1022–1031. doi:10.1002/cncr.21268

    Article  PubMed  Google Scholar 

  18. Li Y, Li Z, Lin HL, Chen XH, Li B (2011) Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature. Pathol Res Pract 207(1):55–59. doi:10.1016/j.prp.2010.05.008

    Article  PubMed  Google Scholar 

  19. Bekkenk MW, Jansen PM, Meijer CJ, Willemze R (2004) CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 15(7):1097–1108. doi:10.1093/annonc/mdh268

    Article  PubMed  CAS  Google Scholar 

  20. Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP (2007) Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 109(4):1720–1727. doi:10.1182/blood-2006-04-018143

    Article  PubMed  CAS  Google Scholar 

  21. Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D (2006) Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol 19(12):1555–1562. doi:10.1038/modpathol.3800679

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea

    Ho Jung An, Dok Hyun Yoon, Shin Kim & Cheolwon Suh

  2. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

    Su-Jin Shin & Jooryung Huh

  3. Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

    Kyoo-Hyung Lee

Authors
  1. Ho Jung An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dok Hyun Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Su-Jin Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jooryung Huh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyoo-Hyung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cheolwon Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cheolwon Suh.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 152 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

An, H.J., Yoon, D.H., Kim, S. et al. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Ann Hematol 92, 351–356 (2013). https://doi.org/10.1007/s00277-012-1614-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1614-z

Keywords

Search

Navigation